Veta-Grand

Veta-Grand is a Russian biotechnology and pharmaceutical company specializing in the development and manufacture of photosensitizers for Photodynamic Therapy (PDT). The company's flagship product, Photoditazin (Fotoditazin), is a second-generation chlorin e6-based photosensitizer widely used in the treatment of various oncological conditions, including skin, lung, and bladder cancers. Beyond oncology, Veta-Grand focuses on applications in gynecology for the treatment of cervical intraepithelial neoplasia and in antimicrobial therapy. Based in Moscow, the company maintains strong collaborations with leading Russian clinical research institutions to advance the field of photomedicine and fluorescence diagnostics.